Stricter Penalties and Crackdowns on Drug-Impaired Driving Implemented Since April

Daewoong Pharmaceutical announced on the 20th that its comprehensive cold medicine, SeeCold Premium, is drawing increased attention in line with recent government crackdowns and stricter penalties for drug-impaired driving.


Photo of C-OLD Premium product. Daewoong Pharmaceutical

Photo of C-OLD Premium product. Daewoong Pharmaceutical

View original image

SeeCold Premium is designed for differentiated daytime and nighttime use. The daytime formula omits chlorpheniramine, a drowsiness-inducing ingredient, to reduce the risk of drowsiness and make it safer for daytime driving and activities.


Since the start of stricter enforcement and penalties for drug-impaired driving on April 2, there has been growing interest in ingredients prohibited for drivers. In particular, chlorpheniramine, an antihistamine commonly used in cold medicine, can cause drowsiness, so caution is needed before driving or performing tasks that require concentration.


SeeCold Premium, relaunched in November of last year, features a customized formula for daytime and nighttime use. The key point is the differentiation of ingredients according to the time of use: the daytime formula supports activity, while the nighttime formula considers sufficient rest.


The main difference between SeeCold Premium and its previous version, SeeCold Plus Tablets, is the removal of chlorpheniramine from the daytime formula. This allows those who are frequently outside for work, drivers, or students who require active daytime functioning to manage cold symptoms without worrying about drowsiness.


The nighttime formula contains diphenhydramine to relieve cold symptoms at night and promote restful sleep without interference. According to the company, this separation based on circadian rhythms enables consumers to intuitively select the product according to the time of day.


Convenience and cost-effectiveness have also been improved. While the previous SeeCold Plus Tablets required taking two tablets per dose, SeeCold Premium achieves effective symptom management with just one tablet per dose. The company explained that this change helps improve medication adherence.


The product’s practicality has also been enhanced. Each box contains a sufficient quantity (approximately 3.3 days’ supply) for intensive management at the onset of a cold, eliminating the inconvenience of additional purchases. This provides an economical and efficient option for customers seeking to address multiple symptoms, such as cough and fever, all at once.



Eunkyung Park, Head of Consumer Healthcare Marketing at Daewoong Pharmaceutical, stated, “SeeCold Premium is a product designed to meet the needs of office workers and students who want to stay focused during the day and recover at night without sleep disturbances, as well as customers seeking safe management of complex cold symptoms. We will continue to prioritize changes in consumer lifestyle patterns and safety, further enhancing differentiated value in the cold medicine market.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing